Bio Techne Corp Stock Performance

TECH Stock  USD 64.63  0.62  0.95%   
On a scale of 0 to 100, Bio Techne holds a performance score of 10. The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bio Techne's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Techne is expected to be smaller as well. Please check Bio Techne's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Bio Techne's price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Techne Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Bio Techne demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
6.25
Five Day Return
8.55
Year To Date Return
15.12
Ten Year Return
223.92
All Time Return
62.7 K
Forward Dividend Yield
0.005
Payout Ratio
0.2119
Last Split Factor
4:1
Forward Dividend Rate
0.32
Dividend Date
2025-11-28
1
Bio-Techne Corp TECH Shares Purchased by Dorsey Whitney Trust CO LLC
11/17/2025
 
Bio Techne dividend paid on 28th of November 2025
11/28/2025
2
Cresset Asset Management LLC Boosts Holdings in Bio-Techne Corp TECH - MarketBeat
12/05/2025
3
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
12/23/2025
4
Research Tools Consumables Stocks Q3 Results Benchmarking Bio-Techne - Yahoo Finance
12/30/2025
5
Rep. April McClain Delaney Purchases Shares of Bio-Techne Corp - MarketBeat
01/06/2026
6
Assessing Bio-Techne Valuation After Recent Share Price Move And Mixed Return Profile
01/09/2026
7
Is Bio-Technes Spatial Biology Push Under New CEO Quietly Redefining Its Core Strategy
01/23/2026
8
CSLLY or TECH Which Is the Better Value Stock Right Now
01/30/2026
9
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
02/02/2026
10
Bio-Techne Q2 2026 Earnings Preview
02/03/2026
Begin Period Cash Flow151.8 M
Total Cashflows From Investing Activities-35.2 M

Bio Techne Relative Risk vs. Return Landscape

If you would invest  5,810  in Bio Techne Corp on November 6, 2025 and sell it today you would earn a total of  1,057  from holding Bio Techne Corp or generate 18.19% return on investment over 90 days. Bio Techne Corp is currently generating 0.2981% in daily expected returns and assumes 2.2095% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Bio, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Bio Techne is expected to generate 2.96 times more return on investment than the market. However, the company is 2.96 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Bio Techne Target Price Odds to finish over Current Price

The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 64.63 90 days 64.63 
about 27.04
Based on a normal probability distribution, the odds of Bio Techne to move above the current price in 90 days from now is about 27.04 (This Bio Techne Corp probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Bio Techne has a beta of 0.74. This usually implies as returns on the market go up, Bio Techne average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bio Techne Corp will be expected to be much smaller as well. Additionally Bio Techne Corp has an alpha of 0.0354, implying that it can generate a 0.0354 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bio Techne Price Density   
       Price  

Predictive Modules for Bio Techne

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Techne Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
62.4264.6366.84
Details
Intrinsic
Valuation
LowRealHigh
58.1776.0078.21
Details
Naive
Forecast
LowNextHigh
55.5557.7659.97
Details
15 Analysts
Consensus
LowTargetHigh
63.7070.0077.70
Details

Bio Techne Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Techne is not an exception. The market had few large corrections towards the Bio Techne's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Techne Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Techne within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.04
β
Beta against Dow Jones0.74
σ
Overall volatility
3.81
Ir
Information ratio 0.01

Bio Techne Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio Techne for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio Techne Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 100.0% of the company shares are owned by institutional investors
Latest headline from seekingalpha.com: Bio-Techne Q2 2026 Earnings Preview

Bio Techne Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bio Stock often depends not only on the future outlook of the current and potential Bio Techne's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Techne's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding159.7 M
Cash And Short Term Investments162.2 M

Bio Techne Fundamentals Growth

Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Techne, and Bio Techne fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.

About Bio Techne Performance

By evaluating Bio Techne's fundamental ratios, stakeholders can gain valuable insights into Bio Techne's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio Techne has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio Techne has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 144.94  86.64 
Return On Tangible Assets 0.05  0.05 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.03  0.03 
Return On Equity 0.04  0.04 

Things to note about Bio Techne Corp performance evaluation

Checking the ongoing alerts about Bio Techne for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Techne Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 100.0% of the company shares are owned by institutional investors
Latest headline from seekingalpha.com: Bio-Techne Q2 2026 Earnings Preview
Evaluating Bio Techne's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bio Techne's stock performance include:
  • Analyzing Bio Techne's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Techne's stock is overvalued or undervalued compared to its peers.
  • Examining Bio Techne's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bio Techne's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Techne's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bio Techne's stock. These opinions can provide insight into Bio Techne's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bio Techne's stock performance is not an exact science, and many factors can impact Bio Techne's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum